Vera Therapeutics Inc. (VERA)
Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
Appili Therapeutics Inc. (APLIF)
Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Cardiol Therapeutics Inc (CRDL)
Cardiol Therapeutics’ Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering
Celcuity Inc. (CELC)
Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call
The Joint Corp (JYNT)
The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program
Anika Therapeutics Inc. (ANIK)
Anika Reports Third Quarter 2025 Financial Results
Mind Medicine (MNMD)
MindMed to Participate in Upcoming Investor Conferences
Charles River Laboratories International Inc. (CRL)
Charles River Laboratories Provides Update on Strategic Review
Viridian Therapeutics Inc. (VRDN)
Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress